The Journal of Clinical Endocrinology & Metabolism · 1976 · 34 citations · 21 references
MedicineEndocrinologyInternal MedicineAutoimmunityDiabetologyGastroenterologyDiabetes MellitusPancreatic DiseasesPancreatic DisordersPancreatic EndocrinologyPancreatic HormonesPancreatic PathologyDiabetes Mellitus PathophysiologyGastric Inhibitory Polypeptide SignalingGlucagon-like PeptidesImpaired Glucose ToleranceInsulin ResponseOral Glucose AdministrationPancreatic Endocrine DysfunctionPancreatic Polypeptide Physiology
The plasma gastric inhibitory polypeptide (GIP), pancreatic glucagon-like immunoreactivity (PGLI), and gut glucagon-like immunoreactivity (GGLI) responses to oral glucose have been measured in five patients with chronic pancreatitis (with diabetic glucose tolerance tests) and in matched nondiabetic controls. Plasma GIP levels rise rapidly after glucose ingestion before changes in circulating glucose and insulin concentration. Patients with pancreatitis have a greater than normal GIP response to oral glucose, which may account for the relatively unimparied insulin response to oral glucose in these patients compared with that to iv glucose, as has been previously found. Patients with pancreatitis also have a paradoxical rise in PGLI and an exaggerated rise in GGLI concentration following oral glucose.
21
Immunoassay of insulin with insulin-antibody precipitate
C. N. Hales, Randle Pj · Biochemical Journal · 1963 · 2.7K citations · Full text
Abnormal Alpha-Cell Function in Diabetes
Walter A. Müller, Gerald R. Faloona, E Aguilar-Parada et al. · New England Journal of Medicine · 1970 · 626 citations
Medicine, Endocrinology, Physiology +14